Associations between vaginal bacteria implicated in HIV acquisition risk and proinflammatory cytokines and chemokines.


Journal

Sexually transmitted infections
ISSN: 1472-3263
Titre abrégé: Sex Transm Infect
Pays: England
ID NLM: 9805554

Informations de publication

Date de publication:
02 2020
Historique:
received: 19 12 2018
revised: 07 05 2019
accepted: 25 05 2019
pubmed: 15 6 2019
medline: 29 4 2020
entrez: 15 6 2019
Statut: ppublish

Résumé

Recent studies have identified vaginal bacterial taxa associated with increased HIV risk. A possible mechanism to explain these results is that individual taxa differentially promote cervicovaginal inflammation. This study aimed to explore relationships between concentrations of bacteria previously linked to HIV acquisition and vaginal concentrations of proinflammatory cytokines and chemokines. In this cross-sectional analysis, concentrations of 17 bacterial taxa and four proinflammatory cytokines (interleukin (IL)-1β, IL-6, IL-10 and tumour necrosis factor alpha (TNFα)) and two proinflammatory chemokines (IL-8 and interferon gamma-induced protein 10) were measured in vaginal swabs collected from 80 HIV-uninfected women. Cytokine and chemokine concentrations were compared between women with bacterial concentrations above or below the lower limit of detection as determined by quantitative PCR for each taxon. Principal component analysis was used to create a summary score for closely correlated bacteria, and linear regression analysis was used to evaluate associations between this score and increasing concentrations of TNFα and IL-1β. Detection of This study provides evidence that several highly correlated vaginal bacterial taxa may influence vaginal cytokine and chemokine concentrations. These results suggest a mechanism where the presence of specific bacterial taxa could influence HIV susceptibility by increasing vaginal inflammation.

Identifiants

pubmed: 31197065
pii: sextrans-2018-053949
doi: 10.1136/sextrans-2018-053949
pmc: PMC6920574
mid: NIHMS1050131
doi:

Substances chimiques

Chemokines 0
Cytokines 0
IL1B protein, human 0
Interleukin-1beta 0
Tumor Necrosis Factor-alpha 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3-9

Subventions

Organisme : NICHD NIH HHS
ID : K24 HD088229
Pays : United States
Organisme : NICHD NIH HHS
ID : P01 HD064915
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI007044
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI027757
Pays : United States
Organisme : NIAID NIH HHS
ID : R37 AI038518
Pays : United States
Organisme : NIAID NIH HHS
ID : K01 AI116298
Pays : United States

Informations de copyright

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: RSM receives research funding, paid to the University of Washington, from Hologic. TLF has a patent, Molecular Diagnosis of Bacterial Vaginosis, licensed to Becton Dickinson. SS, MMM, DAL and TLF report grants from the NIH during the conduct of the study. All other authors have nothing to disclose.

Références

J Acquir Immune Defic Syndr. 2014 Jun 1;66(2):109-17
pubmed: 24413042
Am J Reprod Immunol. 2014 Jun;71(6):555-63
pubmed: 24832618
Clin Vaccine Immunol. 2015 May;22(5):526-38
pubmed: 25761460
J Clin Microbiol. 2009 Mar;47(3):721-6
pubmed: 19144794
AIDS. 2015 Nov;29(17):2279-86
pubmed: 26237099
PLoS Pathog. 2010 Apr 08;6(4):e1000852
pubmed: 20386714
Clin Infect Dis. 2019 May 2;68(10):1675-1683
pubmed: 30407498
J Infect Dis. 2000 Aug;182(2):467-73
pubmed: 10915077
Clin Infect Dis. 2015 Jul 15;61(2):260-9
pubmed: 25900168
Sex Transm Infect. 2008 Feb;84(1):57-61
pubmed: 17911138
Lancet Infect Dis. 2018 May;18(5):554-564
pubmed: 29396006
Mucosal Immunol. 2016 May;9(3):621-33
pubmed: 26349657
Nat Med. 2009 Aug;15(8):886-92
pubmed: 19648930
N Engl J Med. 2005 Nov 3;353(18):1899-911
pubmed: 16267321
ISRN Obstet Gynecol. 2012;2012:342075
pubmed: 22550593
Biochim Biophys Acta. 2014 Nov;1843(11):2563-2582
pubmed: 24892271
BMC Infect Dis. 2008 May 29;8:73
pubmed: 18510764
Immunity. 2013 Dec 12;39(6):1003-18
pubmed: 24332029
PLoS One. 2012;7(6):e37818
pubmed: 22719852
Anaerobe. 2011 Aug;17(4):186-90
pubmed: 21524714
Sex Transm Infect. 2014 Dec;90(8):580-7
pubmed: 25107710
J Clin Microbiol. 1991 Feb;29(2):297-301
pubmed: 1706728
J Acquir Immune Defic Syndr. 2007 May 1;45(1):9-19
pubmed: 17356467
AIDS Res Hum Retroviruses. 2017 Apr;33(4):309-317
pubmed: 27897054
Immunity. 2017 Jan 17;46(1):29-37
pubmed: 28087240
AIDS. 2015 Sep 24;29(15):2025-33
pubmed: 26352880
Immunity. 2015 May 19;42(5):965-76
pubmed: 25992865
AIDS. 2015 Jun 1;29(9):1077-85
pubmed: 26125141
AIDS. 2018 Mar 27;32(6):687-698
pubmed: 29424773
Clin Exp Immunol. 2014 Oct;178(1):1-8
pubmed: 24828133
J Infect Dis. 2014 Jun 15;209(12):1989-99
pubmed: 24403560

Auteurs

Michelle C Sabo (MC)

Department of Internal Medicine, University of Washington, Seattle, Washington, USA sabo@uw.edu.

Dara A Lehman (DA)

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Department of Global Health, University of Washington, Seattle, Washington, USA.

Bingjie Wang (B)

Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.

Barbra A Richardson (BA)

Department of Global Health, University of Washington, Seattle, Washington, USA.
Department of Epidemiology, University of Washington, Seattle, Washington, USA.
Department of Biostatistics, University of Washington, Seattle, Washington, United States.

Sujatha Srinivasan (S)

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.

Lusi Osborn (L)

Department of Research and Programs, Kenyatta National Hospital, Nairobi, Kenya.

Daniel Matemo (D)

Department of Research and Programs, Kenyatta National Hospital, Nairobi, Kenya.

John Kinuthia (J)

Department of Global Health, University of Washington, Seattle, Washington, USA.
Department of Medical Microbiology, University of Nairobi, Nairobi, Kenya.

Tina L Fiedler (TL)

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.

Matthew M Munch (MM)

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.

Alison L Drake (AL)

Department of Global Health, University of Washington, Seattle, Washington, USA.

David N Fredricks (DN)

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.

Julie Overbaugh (J)

Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.

Grace John-Stewart (G)

Department of Internal Medicine, University of Washington, Seattle, Washington, USA.
Department of Global Health, University of Washington, Seattle, Washington, USA.
Department of Epidemiology, University of Washington, Seattle, Washington, USA.
Seattle Children's Hospital, Seattle, Washington, USA.

R Scott McClelland (RS)

Department of Internal Medicine, University of Washington, Seattle, Washington, USA.
Department of Global Health, University of Washington, Seattle, Washington, USA.
Department of Epidemiology, University of Washington, Seattle, Washington, USA.
Department of Medical Microbiology, University of Nairobi, Nairobi, Kenya.

Susan M Graham (SM)

Department of Internal Medicine, University of Washington, Seattle, Washington, USA.
Department of Global Health, University of Washington, Seattle, Washington, USA.
Department of Epidemiology, University of Washington, Seattle, Washington, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH